A “search and destroy” treatment has been found to halt tumours in some men with incurable prostate cancer. The early-stage ...

A global phase 3 trial enrolled mHSPC with ≥90% PTEN loss by IHC and randomized 1,012 patients to intermittent capivasertib plus abiraterone/prednisone versus ...

Astellas Pharma has agreed to co-develop and co-commercialize Vir Biotechnology’s prostate cancer candidate VIR-5500 through a collaboration that could generate more than $1.7 billion for the San ...

President Professor Arthur Peter Mutharika has promulgated Executive Order No. 1 of 2026 on Health Services, in response to reports that public health personnel are soliciting pay ...

Super Bowl champions Bruce Arians and Rob Gronkowski star in a cheeky Super Bowl ad from Novartis designed to encourage men to get screened for prostate cancer with an easy blood test. Arians and ...

The European Society for Medical Oncology has updated its clinical practice guidelines for the management of localised prostate cancer and biochemical recurrence, refining diagnostic pathways and ...

People with diabetes may experience changes in their urinary and digestive health, and research shows there may be different effects on the body impacting the development of prostate cancer. Diabetes ...

A major health update has been shared by the family of former president Joe Biden following the announcement of his aggressive prostate cancer diagnosis. Ashley Biden, the former president’s daughter, ...

Former President Joe Biden, who was diagnosed with an aggressive form of prostate cancer in May, completed a course of radiation treatment Monday, his office said. Biden underwent several weeks of ...

Former President Joe Biden has completed a round of radiation therapy for an aggressive form of prostate cancer. The 82-year-old finished several weeks of therapy at Penn Medicine Radiation Oncology ...

The probability of survival at 8 years was an unprecedented 78.9% with XTANDI plus leuprolide versus 69.5% with leuprolide, in men with non-metastatic hormone-sensitive prostate cancer with high-risk ...